Advertisement
UK markets closed
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • CRUDE OIL

    82.79
    +1.44 (+1.77%)
     
  • GOLD FUTURES

    2,239.60
    +26.90 (+1.22%)
     
  • DOW

    39,760.99
    +0.91 (+0.00%)
     
  • Bitcoin GBP

    55,830.42
    +1,014.82 (+1.85%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • NASDAQ Composite

    16,372.67
    -26.85 (-0.16%)
     
  • UK FTSE All Share

    4,338.05
    +12.12 (+0.28%)
     

If You Invested $25,000 in Abbott Laboratories in 2013, This Is How Much You Would Have Today

If You Invested $25,000 in Abbott Laboratories in 2013, This Is How Much You Would Have Today

It has been more than nine years since Abbott Laboratories (NYSE: ABT) spun off AbbVie (NYSE: ABBV). The move has worked out well for AbbVie, which today has a larger market capitalization than Abbott's. But how has it worked out for Abbott, and would its investors have made the right move if they bought $25,000 worth of shares in the company back then? In 2021, Abbott generated $7.7 billion in revenue from its COVID-19 testing products, which accounted for 18% of its $43.1 billion in total sales.